Cannabis Oversight Shifts as Safety and Scale Drive the News

Canada is considering a major reduction in cannabis reporting requirements, while Colorado regulators warn consumers about contaminated vape products sold statewide. In entertainment, Universal became the first studio to cross $5 billion at the 2026 global box office.

Hemp Sales Face New Limits as Cannabis Oversight Draws Scrutiny

A federal appeals court narrowed protections for hemp sellers in Ohio, an Atlantic City official faces cannabis-related bribery charges, and bipartisan lawmakers proposed a major federal incentive for domestic film and television production.

Cannabis Capital Risks Rise as Paramount Deal Hits a Judicial Pause

Two cannabis lawsuits spotlight financing and data-security risks for licensed retailers, while a federal judge delays approval of the settlement intended to clear Paramount’s Warner Bros. Discovery acquisition.

Cannabis Deal Fight Escalates as Streaming Prices Climb

Aurora Cannabis has taken its battle with Curaleaf to securities regulators, while a federal watchdog identified procedural gaps in U.S. drug scheduling. Disney, meanwhile, is using another round of Disney+ and Hulu price increases to push subscribers toward bundles.

Cannabis Regulatory Gaps, Green Thumb’s Buyback and a Hollywood Megadeal

California’s cannabis regulator is pressing for clearer federal guidance as Green Thumb commits more capital to share repurchases. In Hollywood, a multistate settlement removes a major obstacle to Paramount Skydance’s Warner Bros. Discovery acquisition.

Cannabis Rulebooks Expand as Hollywood Merger Talks Fray

Virginia and Nevada are advancing consequential cannabis regulations covering market entry, retail operations and laboratory testing. In Hollywood, growing opposition and dissent among state attorneys general are complicating settlement talks over Paramount’s proposed Warner Bros. Discovery takeover.

Cannabis Policy Moves as Hollywood Megamerger Talks Accelerate

A bipartisan federal bill targets cannabis-related barriers to government employment, while Maine regulators warn patients about contaminated concentrate. In Hollywood, settlement negotiations could determine the fate of Paramount’s proposed Warner Bros. Discovery takeover.